FB2024_04 , released June 25, 2024
Human Disease Model Report: paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy
Open Close
General Information
Name
paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy
FlyBase ID
FBhh0001355
Disease Ontology Term
Parent Disease
Overview

This report describes paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy (PNKD3); PNKD3 exhibits autosomal dominant inheritance. The human gene implicated in this disease is KCNMA1, which encodes a large conductance, voltage and calcium-sensitive potassium channel (BK or MaxiK channel). KCNMA1 has been implicated in multiple neurological diseases (see MIM:600150). There is a single orthologous gene in Drosophila, slo, for which multiple genetic reagents have been generated, including loss-of-function mutations, overexpression and RNAi targeting constructs, and alleles caused by insertional mutagenesis. Dmel\slo is also orthologous to the related human gene KCNU1.

Multiple UAS constructs of the human Hsap\KCNMA1 gene have been introduced into flies, but have not been used in the context of this disease model.

A variant analogous to a known variant in PNKD3 was introduced into Dmel\slo by homologous recombination; the variant affects an exon shared by all isoforms of slo. Variant(s) implicated in human disease tested (as analogous mutation in fly gene): E366G/E383G in the fly slo (corresponds to D434G in the human KCNMA1 gene). Animals heterozygous for the slo E366G/E383G mutation exhibit locomotor abnormalities at the larval and adult stages; seizure-like phenotypes have not been observed. In previous work in mammalian systems the D434G variant has been shown to act as a gain-of-function mutation by increasing BK channel Ca2+ sensitivity. Work in flies has allowed more detailed characterization of resulting defects in neurophysiology and the neuronal subtypes affected.

Several other diseases postulated to be associated with KCNMA1 have been studied in flies: see 'cardiac arrhythmia (postulated), KCNMA1-related' (FBhh0001351) and 'alcohol, response to, KCNMA1-related' (FBhh0000683). See also human disease model reports for dystonia (FBhh0000039) and epilepsy (FBhh0000268).

[updated May 2021 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy
OMIM report

[PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3](https://omim.org/entry/609446)

Human gene(s) implicated

[POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, ALPHA MEMBER 1; KCNMA1](https://omim.org/entry/600150)

Symptoms and phenotype

Familial paroxysmal nonkinesigenic dyskinesia is a disorder of the nervous system that causes episodes of involuntary movement. Paroxysmal indicates that the abnormal movements come and go over time. Nonkinesigenic means that episodes are not triggered by sudden movement. Dyskinesia broadly refers to involuntary movement of the body. [MedlinePlus (condition), Familial paroxysmal nonkinesigenic dyskinesia; 2021.05.23]

People with familial paroxysmal nonkinesigenic dyskinesia experience episodes of abnormal movement that are brought on by alcohol, caffeine, stress, fatigue, menses, or excitement or develop without a known cause. Episodes are not induced by exercise or sudden movement and do not occur during sleep. An episode is characterized by irregular, jerking or shaking movements that range from mild to severe. [MedlinePlus (condition), Familial paroxysmal nonkinesigenic dyskinesia; 2021.05.23]

The coexistence of epilepsy and paroxysmal dyskinesia in the same individual or family has been described in multiple studies. Du et al. (2005, pubmed:15937479) studied a large family of European descent with the combination of generalized epilepsy and paroxysmal dyskinesia (GEPD). Among 16 affected individuals, 4 developed isolated epileptic seizures, 7 had isolated paroxysmal nonkinesigenic dyskinesia, and 5 had both phenotypes. All patients except 1 had onset of symptoms in infancy or early childhood. [from MIM:609446; 2021.05.23]

Genetics

Paroxysmal nonkinesigenic dyskinesia-3 with or without generalized epilepsy (PNKD3) is caused by heterozygous mutation in the KCNMA1 gene. [from MIM:609446; 2021.05.23]

Cellular phenotype and pathology
Molecular information

MaxiK channels are large conductance, voltage and calcium-sensitive potassium channels which are fundamental to the control of smooth muscle tone and neuronal excitability. MaxiK channels can be formed by 2 subunits: the pore-forming alpha subunit, which is the product of the KCNMA1 gene, and the modulatory beta subunit. Intracellular calcium regulates the physical association between the alpha and beta subunits. [Gene Cards, KCNMA1; 2021.05.16]

The large-conductance voltage- and Ca(2+)-activated K+ channel, also called the BK channel, differs from other K+ channels in that it can be activated by both intracellular Ca(2+) ions and by membrane depolarization. The BK channel consists of 4 alpha subunits and 4 optional auxiliary beta subunits. The pore-forming alpha subunit is encoded by the KCNMA1 gene, which produces multiple isoforms through alternative splicing. The 4 beta subunits are encoded by different genes that show tissue-specific expression (Sausbier et al., 2004; pubmed:15194823). [from MIM:600150; 2021.05.23]

External links
Disease synonyms
generalized epilepsy and paroxysmal dyskinesia
GEPD
PNKD3
Search term: potassium channelopathy
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Many to one: 2 human to 1 Drosophila; the second human gene is KCNU1.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Snapshot
    slowpoke (slo) encodes the structural alpha subunit of a BK ('maxi K') calcium-activated potassium channel. It regulates neurotransmitter release at the synapse and maintain electrical excitability in neurons and muscle cells. [Date last reviewed: 2019-03-14]
    Gene Groups / Pathways
    Comments on ortholog(s)

    High-scoring ortholog of human KCNMA1; moderate-scoring ortholog of KCNU1 (1 Drosophila to 2 human). Dmel\slo shares 52% identity and 64% similarity with KCNMA1.

    Orthologs and Alignments from DRSC
    DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (2 groups)
      protein-protein
      Interacting group
      Assay
      References
      anti tag coimmunoprecipitation, western blot
      anti tag coimmunoprecipitation, western blot
      Alleles Reported to Model Human Disease (Disease Ontology) (14 alleles)
      Models Based on Experimental Evidence ( 6 )
      Modifiers Based on Experimental Evidence ( 8 )
      Models Based on Experimental Evidence ( 1 )
      Allele
      Disease
      Evidence
      References
      Modifiers Based on Experimental Evidence ( 2 )
      Allele
      Disease
      Interaction
      References
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      cre recombinase
      ends-out gene targeting
      loss of function allele
      gamma ray
      CRISPR/Cas9
      ethyl methanesulfonate
      amorphic allele - molecular evidence
      ends-out gene targeting
      References (5)